Raymond James Financial

Raymond James Financial’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Raymond James Financial’s Portfolio EPRX Stock Details EPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$70.3K	Buy
2025 Q1	$36.5K	Sell
2024 Q4	$36.8K	Buy